Intelligence Platform

Patents

Browse 96 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 9617203

Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide

VANDA PHARMACEUTICALS INC. · Granted Tue Apr 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9549913

Treatment of circadian rhythm disorders

VANDA PHARMACEUTICALS INC. · Granted Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9539234

Treatment of circadian rhythm disorders

VANDA PHARMACEUTICALS INC. · Granted Tue Jan 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9458507

Antipsychotic treatment based on SNP genotype

VANDA PHARMACEUTICALS INC. · Granted Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9446038

Method and composition for treating a serotonin receptor-mediated condition

VANDA PHARMACEUTICALS INC. · Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9408839

Antipsychotic treatment based on DRD2 or ANKK1 SNP genotype

VANDA PHARMACEUTICALS INC. · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9328387

Antipsychotic treatment based on SNP genotype

VANDA PHARMACEUTICALS INC. · Granted Tue May 03 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9243295

Antipsychotic treatment based on DRD2 or ANKK1 SNP genotype

VANDA PHARMACEUTICALS INC. · Granted Tue Jan 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9212129

Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide

VANDA PHARMACEUTICALS INC. · Granted Tue Dec 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9157121

Method of treatment based on polymorphisms of the KCNQ1 gene

VANDA PHARMACEUTICALS INC. · Granted Tue Oct 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9138432

Methods for the administration of iloperidone

VANDA PHARMACEUTICALS INC. · Granted Tue Sep 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9072742

Method of predicting a predisposition to QT prolongation

VANDA PHARMACEUTICALS INC. · Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9074254

Method of predicting a predisposition to QT prolongation

VANDA PHARMACEUTICALS INC. · Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9074255

Method of predicting a predisposition to QT prolongation

VANDA PHARMACEUTICALS INC. · Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9074256

Method of predicting a predisposition to QT prolongation

VANDA PHARMACEUTICALS INC. · Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9060995

Treatment of circadian rhythm disorders

VANDA PHARMACEUTICALS INC. · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9057104

Antipsychotic treatment based on DRD2 or ANKK1 SNP genotype

VANDA PHARMACEUTICALS INC. · Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8999638

Method of treatment based on polymorphisms of the KCNQ1 gene

VANDA PHARMACEUTICALS INC. · Granted Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8865210

Stable dosage formulations of imidazolylalkyl-pyridines

VANDA PHARMACEUTICALS INC. · Granted Tue Oct 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8785492

Treatment of circadian rhythm disorders

VANDA PHARMACEUTICALS INC. · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8729100

Method and composition for treating an alpha adrenoceptor-mediated condition

VANDA PHARMACEUTICALS INC. · Granted Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8652776

Prediction of QT prolongation based on SNP genotype

VANDA PHARMACEUTICALS INC. · Granted Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8618134

Method and composition for treating a serotonin receptor-mediated condition

VANDA PHARMACEUTICALS INC. · Granted Tue Dec 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8586610

Methods for the administration of iloperidone

VANDA PHARMACEUTICALS INC. · Granted Tue Nov 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted